Literature DB >> 31697373

Examining the use of economic evaluations in health-related humanitarian programmes in low- and middle-income countries: a systematic review.

Lizna A Makhani1, Valerie Moran2,3, Zia Sadique1, Neha S Singh1, Paul Revill4, Bayard Roberts1.   

Abstract

The costly nature of health sector responses to humanitarian crises and resource constraints means that there is a need to identify methods for priority setting and long-term planning. One method is economic evaluation. The aim of this systematic review is to examine the use of economic evaluations in health-related humanitarian programmes in low- and middle-income countries. This review used peer-reviewed literature published between January 1980 and June 2018 extracted from four main electronic bibliographic databases. The eligibility criteria were full economic evaluations (which compare the costs and outcomes of at least two interventions and provide information on efficiency) of health-related services in humanitarian crises in low- and middle-countries. The quality of eligible studies is appraised using the modified 36-question Drummond checklist. From a total of 8127 total studies, 11 full economic evaluations were identified. All economic evaluations were cost-effectiveness analyses. Three of the 11 studies used a provider perspective, 2 studies used a healthcare system perspective, 3 studies used a societal perspective and 3 studies did not specify the perspective used. The lower quality studies failed to provide 7information on the unit of costs and did not justify the time horizon of costs and discount rates, or conduct a sensitivity analysis. There was limited geographic range of the studies, with 9 of the 11 studies conducted in Africa. Recommendations include greater use of economic evaluation methods and data to enhance the microeconomic understanding of health interventions in humanitarian settings to support greater efficiency and transparency and to strengthen capacity by recruiting economists and providing training in economic methods to humanitarian agencies.
© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  Economic evaluation; cost-effectiveness; disability-adjusted life years; humanitarian crisis; public health interventions

Year:  2020        PMID: 31697373     DOI: 10.1093/heapol/czz144

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  5 in total

1.  Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.

Authors:  Yeji Baek; Zanfina Ademi; Susan Paudel; Jane Fisher; Thach Tran; Lorena Romero; Alice Owen
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

2.  Comparable worth of life for all? Conducting and disseminating health economic evaluations for refugees in Germany.

Authors:  Louise Biddle; Katharina Wahedi; Kayvan Bozorgmehr
Journal:  Global Health       Date:  2022-05-12       Impact factor: 10.401

3.  Considerations for planning COVID-19 treatment services in humanitarian responses.

Authors:  Sylvia Garry; Nada Abdelmagid; Louisa Baxter; Natalie Roberts; Olivier le Polain de Waroux; Sharif Ismail; Ruwan Ratnayake; Caroline Favas; Elizabeth Lewis; Francesco Checchi
Journal:  Confl Health       Date:  2020-11-25       Impact factor: 2.723

Review 4.  Quality in crisis: a systematic review of the quality of health systems in humanitarian settings.

Authors:  Keely Jordan; Todd P Lewis; Bayard Roberts
Journal:  Confl Health       Date:  2021-02-02       Impact factor: 2.723

5.  Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study.

Authors:  Éimhín Ansbro; Sylvia Garry; Veena Karir; Amulya Reddy; Kiran Jobanputra; Taissir Fardous; Zia Sadique
Journal:  Health Policy Plan       Date:  2020-10-01       Impact factor: 3.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.